GUIDELINES FOR USING VERTEPORFIN (VISUDYNE®) IN PHOTODYNAMIC THERAPY TO TREAT CHOROIDAL NEOVASCULARIZATION DUE TO AGE-RELATED MACULAR DEGENERATION AND OTHER CAUSES-Reference-Cited by-同舟云学术

GUIDELINES FOR USING VERTEPORFIN (VISUDYNE®) IN PHOTODYNAMIC THERAPY TO TREAT CHOROIDAL NEOVASCULARIZATION DUE TO AGE-RELATED MACULAR DEGENERATION AND OTHER CAUSES

Published:2002-02 Issue:1 Volume:22 Page:6-18
ISSN:0275-004X
Container-title:Retina
language:en
Short-container-title:Retina

Author:

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Ophthalmology,General Medicine

Reference8 articles.

1. Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration With Verteporfin

2. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization—verteporfin in photodynamic therapy report 2

3. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin

Cited by 114 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Femtosecond pulsed laser photodynamic therapy activates melanin and eradicates malignant melanoma;Proceedings of the National Academy of Sciences;2024-03-29

2. Carrier‐Free, Amorphous Verteporfin Nanodrug for Enhanced Photodynamic Cancer Therapy and Brain Drug Delivery;Advanced Science;2024-03-06

3. Mechanistic investigation of photodynamic therapy using Visudyne in human KB carcinoma cells;Journal of King Saud University - Science;2023-11

4. Verteporfin-mediated on/off photoswitching functions synergistically to treat choroidal vascular diseases;Bioactive Materials;2022-08

5. Targeting mitochondria for cancer photodynamic therapy;Photodiagnosis and Photodynamic Therapy;2022-06